Sale!

HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The HEPACAM Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A (MLC2A) genetic test is a diagnostic examination performed to detect mutations in the HEPACAM gene, which are responsible for the development of MLC2A, a rare neurological disorder. This condition is characterized by an abnormal enlargement of the brain (megalencephaly) and the presence of cysts within the white matter of the brain, leading to a range of neurological symptoms including motor dysfunction, epilepsy, and cognitive delays.

DNA Labs UAE offers this specific genetic test at a cost of 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the HEPACAM gene. This genetic testing is crucial for the accurate diagnosis of MLC2A, enabling healthcare professionals to provide appropriate management and treatment plans for affected individuals. Moreover, it can also offer valuable information for family planning to those who have a history of MLC2A in their family.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test

Cost: AED 4400.0

Symptoms and Diagnosis

Megalencephalic leukoencephalopathy with subcortical cysts 2A (MLC2A) is a neurological disorder characterized by progressive white matter abnormalities in the brain. This leads to megalencephaly (enlarged brain) and the formation of cysts in the subcortical regions. To diagnose MLC2A, a genetic test called HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test can be conducted.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to conducting the HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with MLC2A.

Test Details

The HEPACAM gene is associated with MLC2A. NGS genetic testing is used to analyze multiple genes simultaneously, allowing for a comprehensive examination of an individual’s genetic makeup. In the case of MLC2A, NGS genetic testing can identify mutations in the HEPACAM gene, which is responsible for causing the disorder. By identifying these mutations, healthcare professionals can accurately diagnose MLC2A, providing crucial information for understanding the underlying cause of the disease and guiding appropriate treatment and management strategies.

Test Name HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HEPACAM Gene Megalencephalic leukoencephalopathy with subcortical cysts 2A
Test Details

The HEPACAM gene is associated with a neurological disorder called megalencephalic leukoencephalopathy with subcortical cysts 2A (MLC2A). MLC2A is an autosomal recessive disorder characterized by progressive white matter abnormalities in the brain, leading to megalencephaly (enlarged brain) and the formation of cysts in the subcortical regions.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for a comprehensive examination of an individual’s genetic makeup. In the case of MLC2A, NGS genetic testing can be used to identify mutations in the HEPACAM gene, which is responsible for causing the disorder.

By identifying mutations in the HEPACAM gene through NGS genetic testing, healthcare professionals can make an accurate diagnosis of MLC2A. This information can be crucial for understanding the underlying cause of the disease and guiding appropriate treatment and management strategies.